Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

NeuroVive appoints Daniel Schale as Director of Communications

Lund 4 October 2017 – NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced the appointment of Daniel Schale as Director of Communications. Daniel will report to CFO Catharina Johansson.Daniel Schale will be responsible for the company’s communications, media relations and public affairs. Daniel has ten years of experience in PR and communications, in recent years with special focus on pharmaceuticals, biotech and life science. Daniel holds an M.Sc. in Economics from Lund University. ”The recruitment of Daniel to NeuroVive

Preliminary revenue July – September 2017

Based on the information available for the period July-September 2017, G5 forecasts quarterly revenue of approximately SEK 265 M, which corresponds to achieving 110 per cent revenue growth versus comparable figures for the same period 2016. For the interim period January-September 2017, G5 forecasts revenue of approximately SEK 776 M, which corresponds to achieving 134 per cent revenue growth versus comparable figures for the same period 2016. Vlad Suglobov, G5´s CEO, comments: “We do not normally comment on currency exchange rates, but it is a special situation in this quarter. Since

Peptonic Medical recruits Brand Manager

Stockholm, 4th October, 2017 – Peptonic Medical (publ) (‘Peptonic’ or ‘Company’) today announces that it has recruited Mr Erik Sundquist as VagiVital™ Brand Manager. In his role, Mr Sundquist will be responsible for the commercialisation of the Product – a vaginal gel developed in-house for the treatment of vaginal atrophy and vaginal dryness.Mr Sundquist has many years of experience from marketing and sales of medical device products both nationally and internationally. From 2002 to 2006, Mr Sundquist held the position as Nordic Head and later as European Head at Q-Med. In these positions

Eniro completes recapitalisation plan

Eniro AB (publ) completes the recapitalisation plan and the exchange offers. The bank consortium and the underwriting consortium have given their consent to complete the exchange offers, despite that a 95 percent acceptance level was not achieved. Final approval from the banks’ credit committees are expected no later than Thursday 5 October 2017. Eniro’s board of directors has, as communicated in the press release dated 3 October 2017, decided to complete the exchange offers at the achieved acceptance level, provided approval is given by Eniro’s banks and the underwriting consortium.

Talouselämä will undergo a redesign

Alma Media Corporation        Press Release, 4 October, 2017 TALOUSELÄMÄ WILL UNDERGO A REDESIGN The largest financial magazine in the Nordic countries, Talouselämä, published by Alma Talent, will undergo a redesign. A new online service will be launched today, Wednesday 4 October 2017, and the first redesigned magazine will come out on Friday. The Talouselämä magazine and its online service will feature more extensive content and offer an even closer look at the news relevant to the economy and society, providing in-depth background information. The analysis and reports offered by

Ayima NYC Office Signs New Client Contract

Ayima’s New York operation signed a major new client yesterday. The client is a major international Financial Services company and the engagement is initially for SEO consulting services. As is standard practice, the new engagement consists of a long-term retainer agreement for a minimum of 12 months, renewing indefinitely and there is scope to expand the services to the UK and other geographic markets in the near future. The value of the contract will be a minimum of USD360,000 (2.95 MSEK) in the first year. The new engagement will commence during October 2017 and begin to be

Nomination Committee for Eastnine’s 2018 Annual General Meeting

In accordance with the decision by the Annual General Meeting (AGM) in May 2017, Eastnine shall have a Nomination Committee comprising at least three but no more than four members, of which up to three members shall be appointed by the three largest shareholders (or group of shareholders) that wish to appoint a representative. The fourth member shall be the Chairman of the Board of Directors. The members of the Nomination Committee have been appointed based on the ownership structure as of 31 August 2017. The Nomination Committee, convened by Lars O Grönstedt, comprises Magnus Lekander

Bactiguard's central venous catheters approved in Hong Kong

The Hong Kong product approval for Bactiguard's central venous catheters for infection prevention has been announced by the Medical Device Control Office. Hong Kong is a small, but strategically important market, as it serves as a reference for new approvals and market acceptance in neighbouring China.The Medical Device Control Office in Hong Kong, has announced the regulatory approval of Bactiguard’s central venous catheters for infection prevention (BIP CVC). The approval was confirmed much earlier than expected. This means Bactiguard can start marketing activities 8-9 months earlier than

Hexagon acquires Luciad, a leading provider of 5D visualisation and analysis solutions

Hexagon AB, a leading global provider of information technologies that drive productivity and quality across geospatial and industrial enterprise applications, announces the acquisition of Luciad, a Belgian-based software company specialising in the visualisation and analysis of real-time geospatial information.Luciad’s visualisation technologies support live connections to dynamic sensor feeds in a 3D environment. The result is a 5D digital reality – real-time, rapid fusion of multi-source content and the ability to perform analytics on-the-fly. These intuitive command and control

Orkla ASA: Notice of Extraordinary General Meeting

An Extraordinary General Meeting of Orkla ASA will be held at Oslo Concert Hall, Munkedamsveien 14, Oslo, on Wednesday 25 October 2017 at 10 a.m.   Notice of attendance must be received no later than 3 p.m. (Norwegian time) on 23 October 2017. Attached you will find the notice to the General Meeting.   The Notice is posted electronically or by mail to all shareholders, and may also be found at www.orkla.com.   The Extraordinary General Meeting will be simultaneously interpreted to English, and both languages will be webcast at www.orkla.com.   Registration will open

IRLAB starts Phase II study with IRL752 for the treatment of Parkinson’s disease dementia

The randomized, double blind and placebo controlled study with the drug candidate IRL752 has been initiated with the first dosing. The study aims to provide information on the safety, tolerability and efficacy of IRL752 in patients with Parkinson’s disease dementia. Today, there is a lack of effective treatment options for these patients and thus, the medical needs are large. The study, which is carried out in Scandinavia, is planned to recruit about 40 patients and a have a treatment duration of four weeks. The study is estimated to be concluded during the second quarter of 2018.The Phase

Skanska expands Portland International Airport in Portland, USA, for USD 151M, about SEK 1.3 billion

Skanska has signed a contract with The Port of Portland for the expansion and renovation of Portland International Airport in Portland, Oregon, USA. The contract is worth USD 151M, about SEK 1.3 billion, which will be included in the US order bookings for the third quarter 2017.The project entails a 14,000 square meter, about 250 meter long two-story expansion of Concourse E, including the addition of six additional gates. The scope also includes airside sitework, modifications to baggage handling systems and various renovations within the existing terminal. The project will increase the

RepRisk opens new Americas hub in Toronto

Global presence enables 24-hour business operationsZurich, Switzerland – October 4, 2017 – RepRisk, the leading provider of research and metrics on ESG risk and business conduct, is proud to announce the opening of an office in Toronto, Canada. Through a global presence with RepRisk offices in Canada, Germany, the Philippines, and Switzerland, RepRisk moves to a setup that allows for 24-hour business operations. This further improves RepRisk’s ability to serve its clients, which include the world’s largest financial institutions and corporates. Soon, RepRisk will also have 24-hour client

Multiconsult ASA – Repurchase of own shares

On 3 October 2017, Multiconsult ASA ("Multiconsult") purchased 1 444 of its own shares at an average price of NOK 86.67 per share. The shares were purchased in accordance with the Company's share repurchase programme, as announced on 22 September 2017. The shares were acquired on Oslo Børs. Following this transaction Multiconsult holds 26 145 of its own shares. For further information, please contact: Investor relations: Mirza Koristovic, Head of Investor RelationsPhone: +47 93 87 05 25E-mail: ir@multiconsult.no Media: Gaute Christensen, VP CommunicationsPhone: +47

BAKKAFROST: Q3 2017 TRADING UPDATE

Harvest volumes in Q3 2017 are Farming North 1.7 thousand tonnesFarming West 9.9 thousand tonnesTotal Q3 2017 11.6 thousand tonnes The harvest volumes are provided in head on gutted (HOG) equivalents. Feed sales in Q3 2017 are 22.3 thousand tonnes. Havsbrún sourced 22.2 thousand tonnes of raw materials in Q3 2017. The full Q3 2017 report will be released on 14 November 2017 at 06:00 CET. Contacts: Regin Jacobsen, CEO of P/F Bakkafrost: +298 23 50 01 (mobile) Gunnar Nielsen, CFO of P/F Bakkafrost: +298 23 50 60 (mobile) This information is subject of the

Akastor ASA: Invitation to presentation of third quarter results 2017

Akastor ASA will publish its third quarter 2017 results on Wednesday October 25, 2017 at 7:00 a.m. CET. The presentation will be available through a conference call and audiocast only, at 8:00 a.m. CET. The presentation will be audiocasted live, and available through a dial-in conference call. There will be a Q&A session following the presentation.The replay will be made available on the company website. Live webcast link: http://webtv.hegnar.no/presentation.php?webcastId=68580514 Dial in details:Local - USA +1 719-325-4756Local - UK +44 (0)330 336 9105Local - Norway +47

Saab Combat Management System Announced as Choice for Royal Australian Navy

Defence and security company Saab has been identified by the Australian government to provide the tactical interface to the Royal Australian Navy’s (RAN) fleet of nine Future Frigates. The Saab 9LV Combat Management System would form an integral part of the Future Frigate and upgraded Air Warfare Destroyer combat capability as well as being selected for the Offshore Patrol Vessels.Over the last 30 years in Australia Saab has established a strong relationship with the Royal Australian Navy, delivering the combat management systems for the ANZAC class frigates, Canberra class Landing

Premiere for Air Arabia Maroc between Agadir and Stockholm

Now Swedish passengers will have an additional low cost alternative to choose from among Stockholm Arlanda Airport’s range of destinations. Air Arabia Maroc was welcomed to Arlanda on Tuesday evening. A ribbon cutting ceremony inaugurated the new non-stop route between Agadir in southern Morocco and Stockholm, Sweden. “We welcome Air Arabia Maroc, which is the fifth new low cost carrier at Stockholm Arlanda within a year. We believe that Agadir is a destination which will grow rapidly in popularity among Swedes when the new route allows even more passengers to fly non-stop,” said

Hansa Medical’s Capital Market Days provide an update on number of patients included in the company’s kidney transplantation and anti-GBM studies

Hansa Medical AB (Nasdaq Stockholm: HMED), a biopharmaceutical company focusing on novel immunomodulatory enzymes, today announced that on its Capital Markets Days in Stockholm, the company presented an update on the number of patients included in the company’s clinical studies.Hansa Medical’s Capital Market Day in Stockholm attracted an audience of some 70 people at IVA Konferenscetrum in Stockholm and was followed live via webcast by an additional 270 viewers. Senior management from Hansa Medical, including Göran Arvidson, Dr Christian Kjellman, Dr Lena Winstedt, Dr Sam Agus, Henk Doude

Catena Media appoints Henrik Persson Ekdahl as acting CEO

The Board of Catena Media Plc has today appointed Henrik Persson Ekdahl as acting CEO with immediate effect and Robert Andersson leaves as CEO of the company. The board of directors has initiated this CEO change in order to fulfill the company’s strategy, continued growth and to increase shareholder value.Henrik Persson Ekdahl is a member of the board of directors of Catena Media and also a partner in Optimizer Invest Ltd, one of the main owners of Catena Media. He replaces former CEO Robert Andersson. The Board would like to express its gratitude to Robert for his outstanding efforts and

Summons to attend the Extraordinary General Meeting of Investment AB Latour (publ)

The shareholders in Investment AB Latour (publ) (“Latour”) are hereby summoned to attend the Extraordinary General Meeting Wednesday 25 October 2017 4:00 p.m. at J.A. Wettergrens gata 7, Västra Frölunda, Sweden. NotificationShareholders who wish to participate in the Extraordinary General Meeting must be inscribed in the register of the shareholders held by Euroclear Sweden AB no later than Thursday 19 October 2017 and notify their intent to participate no later than 3 p.m., Thursday 19 October 2017. Notification can be made per telephone +46 31 89 17 90, or by mail to Latour, Box

EXPIRATION OF VOLUNTARY OFFER PERIOD FOR WEIFA ASA – ACQUISITION SUCCESSFUL WITH ACCEPTANCES AT +97,1 %

· On expiration of the offer period on 3 October, 2017 at 16:30 CEST, Karo Pharma AB ("Karo Pharma") had received acceptances for the voluntary offer ("Voluntary Offer") to acquire all shares in Weifa ASA ("Weifa") for a total of 35 414 529 shares representing approximately 97,1 % of the total shares in Weifa on a fully diluted basis. · The conditions for completion of the Voluntary Offer have been met. In accordance with the terms and conditions set out in the offer document, settlement according to the Voluntary Offer will take place as soon as possible and within two weeks from the

Orexo appoints Nomination Committee and publishes financial calendar 2017/2018

Uppsala, Sweden – October 3, 2017 – Prior to the Annual General Meeting 2018, Orexo appoints a Nomination Committee which represents approximately 45 percent of the number of shares and votes in the company based on the last known shareholder information. The Nomination Committee, whose tasks include providing proposals to the General Meeting regarding Chairman of the Meeting, Board members, Chairman of the Board, fees for the board members, any remuneration for committee work, proposal for and fees to the company’s auditor as well as principles for composition of the Nomination

Realfiction Holding AB appoints new Chief Financial Officer

Today, October 3, 2017, Realfiction Holding AB ("Realfiction") has appointed 36-year old Thomas Jæger to the position as new CFO for the company. Thomas will be joining Realfiction from October 23, where he will be taking over from current part-time CFO Anya Mantzius.With a strong background in accounting, Thomas has previously held positions at Ernst & Young  and PwC, before moving on to Royal Unibrew A/S, listed on the Copenhagen Stock Exchange, where he held various positions during his years of employment. In his latest position, Thomas has worked as CFO for the Danish company

There are no items matching the current filter
There are no more items matching the current filter
Back to top